4 completed, 1 recruiting. 5 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Non-obstructive Hypertrophic Cardiomyopathy: new trials by email Literature Review of Non-obstructive Hypertrophic Cardiomyopathy trials Research Report on Non-obstructive Hypertrophic Cardiomyopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Ninerafaxstat 200mg MR, Placebo - Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | Recruiting | Imbria Pharmaceuticals, Inc. | 165 | 2025-10-06 | 2026-10-26 |
| A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy HRS-1893, HRS-1893 placebo - Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | Completed | Shandong Suncadia Medicine Co., Ltd. | 84 | 2025-02-25 | 2026-08-24 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial IMB-1018972, Placebo - Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | Completed | Imbria Pharmaceuticals, Inc. | 67 | 2021-06-14 | 2024-04-23 |
| A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM mavacamten - Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy | Phase 2 / Phase 3 | Completed | Bristol-Myers Squibb | 314 | 2018-09-27 | 2026-02-20 |
| A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) mavacamten, Placebo - Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | Completed | MyoKardia, Inc. | 59 | 2018-03-30 | 2022-08-09 |
Cardiomyopathy, Hypertrophic (2)
Aortic Stenosis, Subvalvular (2) · Aortic Valve Disease (2) · Aortic Valve Stenosis (2) · Cardiomyopathies (2) · Cardiovascular Diseases (2) · Heart Diseases (2) · Heart Valve Diseases (2)
MYK-461 (2)
Imbria Pharmaceuticals, Inc. (2) · Bristol-Myers Squibb (1) · MyoKardia, Inc. (1) · Shandong Suncadia Medicine Co., Ltd. (1)
United States (4) · United Kingdom (3) · Belgium (2) · France (2) · Germany (2) · Italy (2) · Netherlands (2) · Poland (2) · Portugal (2) · Spain (2) · Austria (1) · China (1) · Czechia (1) · Denmark (1) · Israel (1)